SCHEMBL7746649

SCHEMBL7746649

O=C(Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1ccccc1Cl)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.47
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
HDAC1 Q13547 3/20 0.44
HDAC2 Q92769 2/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
DEGS1 O15121 1/20 0.43
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
CCNA1 P78396 1/20 0.42
AGPAT2 O15120 2/20 0.41
SERPINE1 P05121 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739068 0.92 KDR (0.47) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7746598 0.89 KDR (0.58) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7744754 0.89 HDAC2 (0.48) HDAC2MEN1KMT2ALMNAABCG2
SCHEMBL7744662 0.88 KDR (0.61) KDRFLT1FLT4HDAC1LMNA
SCHEMBL7985537 0.88 KDR (0.53) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7744059 0.87 KDR (0.53) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7746655 0.84 KDR (0.43) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7744162 0.82 KDR (0.45) KDRFLT1FLT4HDAC1AGPAT2
SCHEMBL7744086 0.82 KDR (0.51) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7744167 0.82 HDAC1 (0.53) KDRFLT1FLT4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed